CLINICAL EVENTS CALENDAR
Non-Accredited Education
CLINICAL EXPERIENCE WITH A NEW HYBRID CORONARY WIRE On Demand Web ArchiveNon-Accredited Target Audience: Physicians, nurses, and technologists. This activity is supported by an educational grant from Terumo Medical Corporation. |
Srihari S. Naidu MD
History
- Blog
- View recent blog entries
- Member for
- 16 weeks 5 days
My Information
- First Name
- Srihari S. Naidu, MD
- Last Name
- Naidu
- My Bio
Srihari “Hari” Naidu, MD, Director of the Cardiac Catheterization Laboratory, Interventional Cardiology Fellowship Program, and Hypertrophic Cardiomyopathy Center at Winthrop-University Hospital in Long Island is a busy interventionalist skilled in all aspects of interventional cardiology including ASD/PFO closure, alcohol septal ablation for hypertrophic cardiomyopathy, aortic and mitral valvuloplasty, percutaneous ventricular assist devices, as well as peripheral and coronary intervention.
His post-graduate training included fellowships in general and interventional cardiology at the University of Pennsylvania, where he received the 2004 Outstanding Teaching Award. He completed his residency in internal medicine at New York Hospital-Cornell Medical Center, and received his undergraduate and medical degrees from Brown University, where he remains associated as a Member of the Medical School Board of Directors and President of the Undergraduate Class of 1993.
As a recognized expert in the management of patients with Hypertrophic Cardiomyopathy, Dr. Naidu also runs a comprehensive, multi-disciplinary Hypertrophic Cardiomyopathy Center, and represents the Society for Cardiovascular Angiography and Intervention (SCAI) on the upcoming 2010 AHA/ACC Guidelines for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy.
Dr. Naidu has published over 65 original articles, book chapters and abstracts on angioplasty outcomes, new technology, innovative procedural modifications and hypertrophic cardiomyopathy. He also sits on several nationally-appointed committees, including the ACC Interventional Science Council, AHA Scientific Program Committee, and TCT State Representative and Advisory Board. In addition, he routinely serves as Invited Speaker for the ACC, AHA, SCAI and TCT Scientific Sessions.
Cardiology Blogs
All Subscriptions are FREE to qualified cardiology professionals

- Subscribe to:
- Journal
- Digital Journal
- E-News
- RSS feed
Anytown, California
Press Release
— Bethlehem, Pennsylvania – Invatec received 510(k) clearance from the U.S. Food and Drug Administration (FDA) in October to market its Mo.Ma Ultra Proximal Cerebral Protection Device for use during carotid artery stenting (CAS). The device effectively reduces and captures debris released during the stenting procedure to prevent it from traveling to the brain, where it has the potential to cause a stroke.
CME Showcase
![]() The Use of Remote Robotic Navigation in Complex Arrhythmias Complimentary Accredited Web Archive This activity is designed for electrophysiologists and EP allied professionals. Diagnosing Coronary Artery Disease: Advanced Cardiovascular Imaging Solutions New Standards of Care for CRMD Antibiotic Protection Complimentary CME Accredited Webcast Dates: November 18, 2008 Time: 6:00 pm ET November 19, 2008 Time: 3:00 pm ET This activity is sponsored by the North American Center for Continuing Medical Education. |




















